Op-ed: Dems Set Trump Up for False Healthcare ‘Fail’
By Catherine Salgado | Published December 3, 2025 in PJ Media
The Biden administration appears to have set a trap for the Trump administration with a federal provision for funding specialized senior healthcare.
The Trump White House is now weighing options for an allegedly “urgent” Medicare Part D issue tied to the Biden Inflation Reduction Act, which is to take effect on Jan. 1 of next year. The Senior Care Pharmacy Coalition (SCPC) claims that if the new policy takes effect, specialized long-term-care (LTC) pharmacies serving American nursing homes will not be able to remain open.
Advocates assert that numerous seniors won’t be able to access medications, and nursing homes might even close. The Biden administration set Donald Trump up to take a fall. Without passage of the “Preserving Patient Access to Long-Term Care Pharmacies Act,” which would create a temporary supply fee, SCPC insists that the cost to taxpayers through Medicare will become even higher.
An unnamed source described as close to the administration said, “The Biden administration left a number of trap doors of bad policies, and they were hoping President Trump would fall into them ahead of the election. Thankfully, there is a whole-of-government effort to fix and replace the broken, government-run health care system the Democrats imposed on America.”
The reality is that it is incredibly alarming that numerous pharmacies are so utterly dependent on the federal government that they would not be able to operate properly without this. The federal government should never have been involved in healthcare to begin with, and its involvement has been a disaster ever since. But Democrats love to get government involved because it means that they control healthcare when they are in power, and they can blame Republicans for healthcare crises when they are not in power. That’s what is happening here.
An SCPC press release shared with PJ Media explained:
The SCPC analysis, based on the Medicare Current Beneficiary Survey data and the Medicare Fee-for-Service claims data, estimates that if utilization increased just 1% per year due to LTC pharmacy closures and service reductions and if medical inflation is 4.3% – the current CMS medical inflation rate for 2026-2033– Medicare spending will increase $1.9 billion over 10 years. If utilization increases 2.5% – a realistic possibility given the magnitude of the impact on LTC pharmacies– Medicare spending would increase $4.8 billion over 10 years. By contrast, the cost of fixing the problem now and averting this crisis is only $826 million over 10 years.
Hence, the SCPC’s sense of urgency.
As noted above, it appears that the taking effect of the previous provision set under the Biden administration was placed as a clever trap should the Democrats not win the 2024 election. It could therefore be weaponized against the Trump administration as a claim of abandoning senior citizens.
Besides the act mentioned above as a solution, which could be included in a year-end ACA subsidy package, the Trump administration could also choose to use Section 402 authority to set a temporary dispensing fee, according to the advocacy group.
Read the full article on PJ Media here
Recent Posts
-
SCPC Submits Second Round of Comments to Healthcare Advisory Committee
The Senior Care Pharmacy Coalition submitted comments yesterday to the Healthcare Advisory Committee (HAC). The HAC is a group of experts charged with delivering strategic recommendations directly to the HHS Secretary and CMS Administrator to improve how care is financed and delivered across Medicare, Medicaid and the Children’s Health Insurance Program (CHIP), and the Health […]
-
SCPC Responds to Senate Finance Committee Request for Information on Commonsense Policy Options to Lower Drug Prices for Patients
The Senior Care Pharmacy Coalition (SCPC), the leading voice for the nation’s long-term care (LTC) pharmacy community, submitted comments to the Senate Finance Committee’s Request for Information (RFI) seeking input on commonsense policy options to lower drug prices for patients. “SCPC supports the Committee’s focus on reducing prescription drug costs while preserving beneficiary access and […]
-
LTC pharmacies said this would happen. New data says they were right.
By Donna Shryer // Published July 18, 2026 in McKnight’s Long-Term Care News Long-term care pharmacies predicted a steep reimbursement hit from the Inflation Reduction Act’s Medicare drug pricing changes. Now they say they have the data confirming it. A new analysis of member financial data shows reimbursement for drugs subject to the law’s negotiated […]
Stay Connected
Get the latest news and updates on issues impacting the long-term care pharmacy community.